当前位置: X-MOL 学术J. Pediat. Inf. Dis. Soc. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Ganciclovir and Valganciclovir Use Among Infants With Congenital Cytomegalovirus: Data From a Multicenter Electronic Health Record Dataset in the United States.
Journal of the Pediatric Infectious Diseases Society ( IF 2.5 ) Pub Date : 2022-08-30 , DOI: 10.1093/jpids/piac034
Jessica Leung 1 , Scott D Grosse 2 , Bryan Yockey 1 , Tatiana M Lanzieri 1
Affiliation  

Among 342 US infants with congenital cytomegalovirus treated with antivirals, 114 (33%) received ganciclovir (with or without valganciclovir) and 228 (67%) received valganciclovir only, for a median of 8 and 171 days, starting at a median of 15 and 45 days of life, respectively, with neutropenia diagnosed in 25% and 17%.

中文翻译:

先天性巨细胞病毒婴儿使用更昔洛韦和缬更昔洛韦:来自美国多中心电子健康记录数据集的数据。

在接受抗病毒药物治疗的 342 名患有先天性巨细胞病毒的美国婴儿中,114 名(33%)接受了更昔洛韦(联合或不联合缬更昔洛韦),228 名(67%)只接受了缬更昔洛韦,中位数为 8 天和 171 天,中位数为 15 天和45 天的生命中,中性粒细胞减少症的诊断率分别为 25% 和 17%。
更新日期:2022-05-09
down
wechat
bug